Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status

Mingyang Song, Reiko Nishihara, Molin Wang, Andrew T. Chan, Zhi Rong Qian, Kentaro Inamura, Xuehong Zhang, Kimmie Ng, Sun A. Kim, Kosuke Mima, Yasutaka Sukawa, Katsuhiko Nosho, Charles S. Fuchs, Edward L. Giovannucci, Kana Wu, Shuji Ogino

研究成果: Article

53 引用 (Scopus)

抜粋

Objective Evidence suggests protective effects of vitamin D and antitumour immunity on colorectal cancer risk. Immune cells in tumour microenvironment can convert 25-hydroxyvitamin D [25(OH)D] to bioactive 1α,25- dihydroxyvitamin D3, which influences neoplastic and immune cells as an autocrine and paracrine factor. Thus, we hypothesised that the inverse association between vitamin D and colorectal cancer risk might be stronger for cancers with high-level immune response than those with low-level immune response. Design We designed a nested case-control study (318 rectal and colon carcinoma cases and 624 matched controls) within the Nurses' Health Study and Health Professionals Follow-up Study using molecular pathological epidemiology database. Multivariable conditional logistic regression was used to assess the association of plasma 25 (OH)D with tumour subtypes according to the degree of lymphocytic reaction, tumour-infiltrating T cells (CD3+, CD8+, CD45RO+ (PTPRC) and FOXP3+ cells), microsatellite instability or CpG island methylator phenotype. Results The association of plasma 25(OH)D with colorectal carcinoma differed by the degree of intratumoural periglandular reaction (p for heterogeneity=0.001); high 25(OH)D was associated with lower risk of tumour with high-level reaction (comparing the highest versus lowest tertile: OR 0.10; 95% CI 0.03 to 0.35; p for trend0.50). A statistically non-significant difference was observed for the associations of 25(OH)D with tumour subtypes according to CD3+ T cell density (p for heterogeneity=0.03; adjusted statistical significance level of α=0.006). Conclusions High plasma 25(OH)D level is associated with lower risk of colorectal cancer with intense immune reaction, supporting a role of vitamin D in cancer immunoprevention through tumour-host interaction.

元の言語English
ページ(範囲)296-304
ページ数9
ジャーナルGut
65
発行部数2
DOI
出版物ステータスPublished - 2016 2 1
外部発表Yes

    フィンガープリント

ASJC Scopus subject areas

  • Gastroenterology

これを引用

Song, M., Nishihara, R., Wang, M., Chan, A. T., Qian, Z. R., Inamura, K., Zhang, X., Ng, K., Kim, S. A., Mima, K., Sukawa, Y., Nosho, K., Fuchs, C. S., Giovannucci, E. L., Wu, K., & Ogino, S. (2016). Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status. Gut, 65(2), 296-304. https://doi.org/10.1136/gutjnl-2014-308852